| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MOH
|
429.70 | 211.9B | 19.48 | 3.11 | 9.37 | 16.5% | 8.5% | 67 | 62 | 541.39 | +19.5% | 74 | 0.54 |
|
PEP
|
119.10 | 162.6B | 18.07 | 8.55 | 12.44 | 18.1% | 7.9% | 60 | 60 | 114.81 | -2.7% | 64 | 2.41 |
|
LOR
|
383.90 | 204.9B | 33.44 | 5.86 | 19.35 | 22.6% | 9.3% | 49 | 47 | 248.21 | -26.5% | 87 | 0.34 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.